Tissue-mediated control of immunopathology in coeliac disease.
about
Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapyCo-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigensDietary gluten and the development of type 1 diabetesThe role of the intestinal context in the generation of tolerance and inflammationImmune development and intestinal microbiota in celiac diseaseVaccine against autoimmune disease: antigen-specific immunotherapyT-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac diseaseAntibodies in celiac disease: implications beyond diagnostics.Coeliac disease and gluten sensitivityWheat Allergy and Intolerence; Recent Updates and PerspectivesLeaky gut and autoimmune diseasesGliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cellsTransglutaminase 6: a protein associated with central nervous system development and motor function.IL-15: a central regulator of celiac disease immunopathology.Exploring the influence of the gut microbiota and probiotics on health: a symposium report.Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology.Potential celiac patients: a model of celiac disease pathogenesis.Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease.Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intoleranceNovel therapies for coeliac diseaseRapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challengeMucosal T cells in gut homeostasis and inflammationNovel role of the serine protease inhibitor elafin in gluten-related disorders.Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study.Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation.Intraepithelial lymphocyte distribution differs between the bulb and the second part of duodenumIncreased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis.Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patientsRole of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease.The light and dark sides of intestinal intraepithelial lymphocytesEffect of dietary gluten on dendritic cells and innate immune subsets in BALB/c and NOD miceDefective expression of scavenger receptors in celiac disease mucosa.Epithelial transport of immunogenic and toxic gliadin peptides in vitro.Gut microbes and adverse food reactions: Focus on gluten related disordersThe Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.A 3-D enteroid-based model to study T-cell and epithelial cell interaction.Innate immunity: actuating the gears of celiac disease pathogenesisDistinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease.
P2860
Q24611233-F51B00D6-B1DA-4656-8A5F-A553F6ADDAD8Q24616204-DC00189E-8C55-402F-949C-E17B24233AD0Q26823584-CA24EA44-4E3B-4DB8-9F49-5B9A0C1B46E9Q27001291-0EC58ED7-3391-4183-9546-41758869404BQ27026098-C95C2345-C265-4C9E-BB93-B6B369F28D47Q27028121-C13EB41E-D681-4597-81E0-81C211F7731AQ27690116-3A287BF9-9D5E-48A1-A7CD-90D060C29357Q27693707-99178E33-1652-441E-9AC4-64D296FB01F9Q28235200-2713D5FF-6C61-4EEB-8EAE-DD4B6DB27A41Q28241726-E7A2910E-E47A-4057-8E02-0637AACA153DQ28253767-27BD7BAA-E6B6-4B71-8006-EABFC839825AQ28484010-47F5E4E3-BFD2-4DDD-B3E8-F5B24F5732A0Q30155456-49C38D52-8DFB-4D7B-811F-166A8F40A073Q33788829-B20EF8E8-2947-453F-971C-1FE23A5A8A7BQ33829118-CA4DE144-4CA0-4E65-AC8A-1956619200FCQ33956436-03ADCF31-4ABD-4B98-92BD-2B949CD4C5FBQ33961443-4649C8BF-77D9-4CCF-A5DD-D8E7FA3B527BQ33986375-B85A024A-9291-4B23-B69C-0761C7EB2116Q34040370-76E8D1E5-FCC3-4150-B42F-99BAC0F07DCEQ34170574-BFC373B8-7673-4693-9CA3-54EFE22E55B6Q34206293-3C6ADECE-83C4-403A-B877-3E64F4BD3632Q34291997-E0B5C7B7-AF00-4019-9D3D-50925F77B8C8Q34449346-9D6A1ED2-4F90-4D43-806A-6DE7E62AF0D6Q34474911-5300D999-85A5-4749-9D06-B21F0803136DQ34712071-C83672ED-372B-4A2A-8A23-4C79832D6154Q34809904-77E96B94-F4A7-4D1A-AC26-6424ED9BEC3DQ34932408-0497D82A-4830-4653-93B1-A0505A6D0B0CQ35006277-F80C7B30-A0E4-41F7-A293-DF548A0411EDQ35018831-3AFD2A2A-6172-482F-895E-64AF39E75A23Q35053807-CADBC235-9784-42A2-92B3-A85ECE905F29Q35106620-9F985301-FD9A-4960-94D4-8835195D9F08Q35119562-25E6FCF8-24EF-4F9B-9A03-6D06C969CDFCQ35147881-6CC264D0-DEFD-4022-8DCF-C7D1A0CA77D2Q35196210-05B16220-CA72-418F-8ED8-483DAF9627C9Q35442538-E1139951-72B1-4BDD-8904-B02F0468BDAAQ35498128-9A615FAA-EC7F-4042-BB2A-91990F81EE9BQ35668237-8C14EB71-F2D2-455B-B3B1-AB48A1167742Q35672158-A64BBC70-C7AE-40F6-9667-5039A73D3428Q35733419-E19902D6-1282-4A8B-8FF1-A890BED360A1Q35998352-609FD10B-90DA-4306-BB80-51EB63949E5A
P2860
Tissue-mediated control of immunopathology in coeliac disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tissue-mediated control of immunopathology in coeliac disease.
@en
Tissue-mediated control of immunopathology in coeliac disease.
@nl
type
label
Tissue-mediated control of immunopathology in coeliac disease.
@en
Tissue-mediated control of immunopathology in coeliac disease.
@nl
prefLabel
Tissue-mediated control of immunopathology in coeliac disease.
@en
Tissue-mediated control of immunopathology in coeliac disease.
@nl
P356
P1476
Tissue-mediated control of immunopathology in coeliac disease.
@en
P2093
Bana Jabri
Ludvig M Sollid
P2888
P304
P356
10.1038/NRI2670
P577
2009-12-01T00:00:00Z
P5875
P6179
1019656450